Short answer
PALVELLA THERAPEUTICS, INC. (PVLA) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4/FY2025 earnings release filed Feb 24, 2026: see accompanying exhibit for full financial detail.
PALVELLA THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4/FY2025 earnings release filed Feb 24, 2026: see accompanying exhibit for full financial detail
- CFO Matthew Korenberg signed the filing; actual results and key figures contained in the press release exhibit
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PALVELLA THERAPEUTICS, INC. 8-K filings
Get the next PVLA 8-K as it lands
Follow PVLA for push alerts, or ask the research agent what this filing means.